Eisai
4523.T
#2186
Rank
C$11.69 B
Marketcap
C$41.44
Share price
0.11%
Change (1 day)
0.14%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): C$1.17

According to Eisai's latest financial reports the company's current EPS (TTM) is C$1.20. an increase over its 2024 EPS that were of C$1.35.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025C$1.5111.85%
2024C$1.35-32.63%
2023C$2.005.52%
2022C$1.90-74.01%
2021C$7.31-66.58%
2020C$21.8698.24%
2019C$11.0217.01%
2018C$9.4237.78%
2017C$6.84-27.62%
2016C$9.4535.33%
2015C$6.98-2.82%
2014C$7.18-27.66%
2013C$9.93-27.49%
2012C$13.70-12.67%
2011C$15.6988.08%
2010C$8.34-11.06%
2009C$9.38-390.15%
2008C-$3.23-127.78%
2007C$11.6411.78%
2006C$10.414.38%
2005C$9.977.4%
2004C$9.2943.03%
2003C$6.4925.09%
2002C$5.1952.67%
2001C$3.4069.76%
2000C$2.00